Biotech Matters
by Bluestar BioAdvisors
Ep. 8 – New Frontiers in FSGS: A Discussion of Recent Data and…
About this podcast
Bluestar BioAdvisors team shares insights on drug pipelines and predicts industry trends. Each episode is hosted by a senior member of our New York City based life sciences consulting firm. The host is typically joined by an external expert guest, with whom the host expands on their experiences providing insights and recommendations for industry leaders and emergent innovators, and translating the data of today into the implications for business of science of tomorrow.
Episodes
- Ep. 8 – New Frontiers in FSGS: A Discussion of Recent Data and Developments (with Dr. Howard Trachtman) · 40 min · Episode 8In this episode, Bluestar Principal Jeff Fineberg is joined by Dr. Howard Trachtman, a pediatric nephrologist and researcher, who has been a principal investigator on many NIH…
- Ep. 7 - Heading to Houston: What We're Looking Forward to at ASN Kidney Week 2025 (with Dr. Pietro Canetta) · 47 min · Episode 7Bluestar is once again heading to ASN Kidney Week, this time in Houston, TX. Since our last episode, Otsuka, the manufacturer of sibeprenlimab, announced that the FDA has granted…
- Ep. 6 - B-cells vs. Complement in IgAN: A Look at the Data from Kidney Week 2024 (with Dr. Vlado Perkovic) · 31 min · Episode 6Principal Jeff Fineberg, PhD sits down with Vlado Perkovic, MBBS, PhD, to discuss the IgA nephropathy trial data presented at Kidney Week 2024 in San Diego. Jeff begins by asking…
- Ep. 5 - It's ASN Kidney Week 2024! Here's What We're Excited About (with Dr. Beatrice Goilav) · 18 min · Episode 5Principal Jeff Fineberg, PhD welcomes back returning guest nephrologist Beatrice Goilav, MD, to discuss the program featured at Kidney Week 2024 in San Diego. Dr. Goilav reflects…
- Ep. 4 - ADC Alchemy: A Post-ASCO Discussion · 13 min · Episode 4Bluestar Managing Director Erin Olsen is back from the ASCO conference in Chicago and joins Principal Jeff Fineberg on the podcast again, this time to talk about all things…
- Ep.3 What We're Watching at ASCO 2024 · 17 min · Episode 3As the Bluestar team prepares to head to ASCO 2024 this upcoming weekend, Bluestar Principal Jeff Fineberg sits down with Bluestar Managing Director Erin Olsen to talk about…
- Ep. 2 - Making Sense of the Latest IgAN Trials (with Dr. Pietro Canetta) · 39 min · Episode 2After attending ASN Kidney Week, Bluestar Principal Jeff Fineberg sits down with Dr. Pietro Canetta to talk all things IgA nephropathy (IgAN). After Dr. Canetta provides a brief…
- Ep. 1 - What We're Looking for at ASN Kidney Week 2023: A Conversation with Dr. Beatrice Goilav · 28 min · Episode 1In the first ever Biotech Matters podcast episode, Principal Jeff Fineberg, PhD, sits down with nephrologist Beatrice Goilav, MD, to talk all things Kidney Week. Dr. Goilav…







